Mylan Strikes €642m Deal For Aspen’s Thrombosis Business In Europe

Diversifies Mylan Further Ahead Of Viatris

Europe_Map_Connection
Mylan already has a $4bn business in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business